Comparison of case characteristics between those initiated treatment at outpatient and inpatient sites (n = 256).

<p>Comparison of case characteristics between those initiated treatment at outpatient and inpatient sites (n = 256).</p

Demographic and clinical characteristics of patients who had a diagnosis of laboratory-confirmed RR-TB reported to the COJ for tracing between July 2011 and June 2012 (n = 594).

<p>Demographic and clinical characteristics of patients who had a diagnosis of laboratory-confirmed RR-TB reported to the COJ for tracing between July 2011 and June 2012 (n = 594).</p

Median time from sputum collection to treatment initiation, by treatment site and diagnostic method and proportion initiating treatment by treatment site (n = 256).

<p>Median time from sputum collection to treatment initiation, by treatment site and diagnostic method and proportion initiating treatment by treatment site (n = 256).</p

Unadjusted and adjusted predictors of mortality among patients diagnosed with RR-TB in the COJ between July 2011 and June 2012.

<p>Unadjusted and adjusted predictors of mortality among patients diagnosed with RR-TB in the COJ between July 2011 and June 2012.</p

Subdistribution hazard regression to identify predictors treatment initiating among patients diagnosed with RR-TB in the COJ between July 2011 and June 2012.

<p>Subdistribution hazard regression to identify predictors treatment initiating among patients diagnosed with RR-TB in the COJ between July 2011 and June 2012.</p

Schematic of the procedures and structures established within district health system for the follow-up of all patients diagnosed with RR-TB.

<p>Schematic of the procedures and structures established within district health system for the follow-up of all patients diagnosed with RR-TB.</p

Schematic showing the proportion of those diagnosed with RR-TB in the COJ who were successfully traced and referred and who initiated treatment along with other tracing outcomes including death, moved or transferred out of the city and untraceable.

<p>Schematic showing the proportion of those diagnosed with RR-TB in the COJ who were successfully traced and referred and who initiated treatment along with other tracing outcomes including death, moved or transferred out of the city and untraceable.</p